These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2517443)

  • 61. Accelerated immune red cell destruction in the absence of serologically detectable alloantibodies.
    Davey RJ; Gustafson M; Holland PV
    Transfusion; 1980; 20(3):348-53. PubMed ID: 6770508
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
    Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
    Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients.
    McLeod BC; Piehl MR; Sassetti RJ
    Vox Sang; 1990; 59(3):185-9. PubMed ID: 2124754
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Automatic Marsh method for detection and identification of erythrocyte antibodies in patients and blood donors.
    Michael-Araszkiewicz P; Maślanka K; Kuśnierz G
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):219-24. PubMed ID: 6778450
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The risk of alloimmunization to c (Rh4) in R1R1 patients who present with anti-E.
    Shirey RS; Edwards RE; Ness PM
    Transfusion; 1994 Sep; 34(9):756-8. PubMed ID: 8091462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Anti-G antibodies of the RH-HR blood-group system. II. Studies of the occurrence of the antibodies and their isolation from anti-C + D sera].
    Kuśnierz-Alejska G
    Acta Haematol Pol; 1990; 21(1):81-4. PubMed ID: 2124407
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Delayed hemolytic transfusion reaction associated with Rh antibody anti-f: first reported case.
    O'Reilly RA; Lombard CM; Azzi RL
    Vox Sang; 1985; 49(5):336-9. PubMed ID: 4082530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions.
    Cid J; Ortin X; Elies E; Castellà D; Panadés M; Martín-Vega C
    Transfusion; 2002 Feb; 42(2):173-6. PubMed ID: 11896331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
    Shulman IA; Calderon C; Nelson JM; Nakayama R
    Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Production of additional atypical alloantibodies in Rh(D)-sensitized pregnancies managed by intrauterine investigation methods.
    Pratt GA; Bowell PJ; Mackenzie IZ; Ferguson J; Selinger M
    Clin Lab Haematol; 1989; 11(3):241-8. PubMed ID: 2512046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immune-haemolytic anaemia (IHA) after solid organ transplantation due to rhesus antibodies of donor origin: report of 5 cases.
    Schwartz D; Götzinger P
    Beitr Infusionsther; 1992; 30():367-9. PubMed ID: 1284736
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A mimicking red blood cell autoantibody accompanying transfusion and alloimmunization.
    Wenz B; Gurtlinger K; Wheaton D; Dugan EP
    Transfusion; 1982; 22(2):147-50. PubMed ID: 6803409
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Post-transfusion alloimmunization in patients with sickle cell disease.
    Orlina AR; Unger PJ; Koshy M
    Am J Hematol; 1978; 5(2):101-6. PubMed ID: 104621
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe hemolysis due to a donor anti-D antibody after heart-lung transplantation. Association with lung and blood chimerism.
    Knoop C; Andrien M; Antoine M; Lambermont M; Yernault JC; Dupont E; Goldman M; Estenne M
    Am Rev Respir Dis; 1993 Aug; 148(2):504-6. PubMed ID: 8342916
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Red cell antibodies in frequently transfused patients with myelodysplastic syndrome.
    Stiegler G; Sperr W; Lorber C; Fabrizii V; Höcker P; Panzer S
    Ann Hematol; 2001 Jun; 80(6):330-3. PubMed ID: 11475145
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Severe bleeding in a patient with anti-c alloantibodies and a rare Rhesus phenotype treated with compatible erythrocyte concentrate from the blood bank of the Council of Europe].
    Sonke GS; Overbeeke MA; de Graaff WE; Elisen MG
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2628-32. PubMed ID: 16355576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunohematological findings in myelodysplastic syndrome.
    Novaretti MC; Sopelete CR; Velloso ER; Rosa MF; Dorlhiac-Llacer PE; Chamone DA
    Acta Haematol; 2001; 105(1):1-6. PubMed ID: 11340246
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro investigation of Rh antibodies in pregnant women.
    Lajos J
    Haematologia (Budap); 1982; 15(3):315-21. PubMed ID: 6821044
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Results of the DGTI workshop on the evaluation of the reactivity of monoclonal anti-D.
    Sonneborn HH; Darda C; Ernst M; Flegel WA; Helmbold W; Kasulke D; Kühnl P; Mueller-Eckhardt C; Northoff H; Poschmann A
    Beitr Infusionsther; 1992; 30():382-7. PubMed ID: 1284741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.